HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guido Maura Selected Research

Guido Maura Research Topics

Disease

4Neurodegenerative Diseases (Neurodegenerative Disease)
09/2018 - 07/2002
3Gliosis
01/2022 - 03/2016
3Ischemia
11/2004 - 08/2003
3Brain Ischemia (Cerebral Ischemia)
11/2004 - 08/2003
2Seizures (Absence Seizure)
01/2022 - 03/2016
2Brain Injuries (Brain Injury)
03/2016 - 01/2013
1Epilepsy (Aura)
01/2022
1Neuroinflammatory Diseases
01/2021
1Parkinson Disease (Parkinson's Disease)
08/2018
1Stroke (Strokes)
10/2016
1Colonic Neoplasms (Colon Cancer)
10/2015
1Neoplasms (Cancer)
10/2015
1Neuralgia (Stump Neuralgia)
10/2015
1Pain (Aches)
10/2015
1Disease Progression
09/2013
1Body Weight (Weight, Body)
09/2013
1Weight Loss (Weight Reduction)
09/2013
1Neuroblastoma
01/2012

Drug/Important Bio-Agent (IBA)

6Glutamic Acid (Glutamate)FDA Link
03/2016 - 08/2003
3Polyamine OxidaseIBA
01/2022 - 03/2016
31,2-cyclohexanediamine (dach)IBA
01/2022 - 03/2016
3Adenosine (Adenocard)FDA LinkGeneric
08/2018 - 08/2003
3D-Aspartic Acid (D Aspartate)IBA
11/2004 - 08/2003
2Kainic Acid (Kainate)IBA
03/2016 - 01/2013
25- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA
11/2004 - 08/2003
2Tetrodotoxin (Tetradotoxin)IBA
11/2004 - 08/2003
1SpermineIBA
01/2022
1Ionotropic Glutamate ReceptorsIBA
01/2022
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2022
1Ion Channels (Ion Channel)IBA
01/2022
1PolyaminesIBA
01/2021
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
08/2018
1NeuroglobinIBA
10/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2016
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2015
1brilliant blue (brilliant blue FCF)IBA
10/2015
1Therapeutic UsesIBA
09/2013
1Coloring Agents (Dyes)IBA
09/2013
1Superoxide Dismutase-1IBA
09/2013
1Purinergic P2X7 ReceptorsIBA
09/2013
1coomassie Brilliant BlueIBA
09/2013
1EnzymesIBA
01/2012
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2012
1CalpainIBA
01/2012
1Nitric Oxide Synthase (NO Synthase)IBA
01/2012
1HMGB1 Protein (HMG1)IBA
01/2012
1Purinergic P1 Receptors (Adenosine Receptor)IBA
11/2004
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
11/2004
1Egtazic Acid (EGTA)IBA
11/2004
1Serotonin (5 Hydroxytryptamine)IBA
10/2004
1Serotonin ReceptorsIBA
10/2004
1benzyloxyaspartate (TBOA)IBA
08/2003
1Neuroprotective AgentsIBA
08/2003
11,3-dipropyl-8-cyclopentylxanthineIBA
08/2003
1Amino Acid Transport System X-AG (Glutamate Transporter)IBA
08/2003
1IonsIBA
08/2003
1Pharmaceutical PreparationsIBA
08/2003
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2002
1Superoxides (Superoxide)IBA
07/2002
1Peroxynitrous Acid (Peroxynitrite)IBA
07/2002
1Oxidants (Oxidizing Agents)IBA
07/2002

Therapy/Procedure

1Catheters
10/2015